I and my partner hold BRN through Australian Super Direct Shares facility. Only ASX shares can be held.
We cannot hold overseas listed shares through Australian Super so we will be forced to sell at a huge loss if this goes ahead.
I have emailed IR at brainchip.com pointing out that the announcement's assertion: "I want to reassure our valued shareholders, the vast majority of whom are Australian retail investors, they will be able to buy, hold and sell shares of our new US parent company without restrictions once the US listing has taken effect." - does not take our situation into account, or that of potentially many others.
I think it is vital to keep a dual listing to prevent this unfair forced sale at a huge loss.
- Forums
- ASX - By Stock
- BRN
- Ann: BrainChip Evaluates Redomiciling to US
BRN
brainchip holdings ltd
Add to My Watchlist
0.00%
!
20.0¢

Ann: BrainChip Evaluates Redomiciling to US, page-201
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $405.0M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.0¢ | $1.544M | 7.615M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 61852 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 217258 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32537 | 0.200 |
25 | 968327 | 0.195 |
38 | 1574473 | 0.190 |
40 | 1943108 | 0.185 |
65 | 1281316 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 179258 | 6 |
0.210 | 1653584 | 26 |
0.215 | 846002 | 16 |
0.220 | 1267378 | 34 |
0.225 | 840448 | 18 |
Last trade - 16.20pm 27/06/2025 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online